Caplin Point declares Q1 FY27 unaudited results, recommends dividend

Caplin Point Laboratories Ltd announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The Board of Directors also recommended a Final Dividend of ₹4/- (200%) per equity share for the financial year ended March 31, 2026. Additionally, the company approved the re-appointment of Dr. Sridhar Ganesan as Managing Director and the appointment of Mr. D. Muralidharan as Whole-Time Director. The 35th Annual General Meeting is scheduled for September 25, 2026.